Trial Profile
Phase II Study of Single Agent RAD001 in Patients with Colon Cancer and Activating Mutations in the PI3KCA gene.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 15 Oct 2014
Price :
$35
*
At a glance
- Drugs Everolimus (Primary)
- Indications Colon cancer
- Focus Therapeutic Use
- 25 May 2011 New trial record